SCHEMBL19919792

SCHEMBL19919792

Cc1cc(-c2cc(-n3c4cc(C(F)(F)F)ccc4c4ccc(C(F)(F)F)cc43)c(-n3c4cc(C(F)(F)F)ccc4c4ccc(C(F)(F)F)cc43)cc2C#N)cc(C)n1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KIF11 P52732 1/20 0.36
XDH P47989 2/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
MAT2A P31153 5/20 0.35
GRM5 P41594 2/20 0.34
CYP11B2 P19099 1/20 0.34
GRM2 Q14416 1/20 0.34
SCN9A Q15858 1/20 0.34
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909071 0.96 TSHR (0.36) TSHRSMN1; SMN2KIF11XDHALOX5AP
SCHEMBL19909076 0.95 KIF11 (0.43) TSHRSMN1; SMN2KIF11XDHALOX5AP
SCHEMBL19909522 0.92 KIF11 (0.39) TSHRSMN1; SMN2KIF11XDHALOX5AP
SCHEMBL19909402 0.90 ALOX5AP (0.38) TSHRSMN1; SMN2XDHALOX5APFEN1
SCHEMBL19909532 0.89 ALDH1A1 (0.32) TSHRSMN1; SMN2KIF11GRM2
SCHEMBL22563399 0.88 TSHR (0.38) TSHRSMN1; SMN2KIF11XDHALOX5AP
SCHEMBL19913225 0.88 KIF11 (0.36) TSHRSMN1; SMN2KIF11XDHALOX5AP
SCHEMBL19909515 0.88 KIF11 (0.43) TSHRSMN1; SMN2KIF11XDHMAT2A
SCHEMBL19903506 0.88 KIF11 (0.37) TSHRSMN1; SMN2KIF11XDHALOX5AP
SCHEMBL21278863 0.85 TSHR (0.36) TSHRSMN1; SMN2KIF11XDHALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 TSHR 3463/4885SMN1; SMN2 4471/4885KIF11 3067/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 TSHR 3186/4885SMN1; SMN2 4607/4885KIF11 3082/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 TSHR 3463/4885SMN1; SMN2 4471/4885KIF11 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.